Brussels. New immunisation technologies, 12 clinical trials, 248 scientific publications, and 6 patents are the result of six years of work in the now concluded European research project ADITEC – Advanced Immunisation Technologies. The results were presented at the University of Siena at the final meeting. ADITEC, which was launched in 2011, was funded within the 7th Framework Programme for Research and Innovation of the European Union with €30 million. The 42 partners from 14 countries were coordinated by Rino Rappuoli, President of the Sclavo Vaccines Association (SVA), and by Donata Medaglini of the University of Siena. (9colonne)
